Cargando…
Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines
BACKGROUND: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report serotypes, their associated disease potential and coverage of pneumococcal conjugate vaccines (PCV) in adults with NBP and compare these to bacteremic pneumonia (BP). METHODS: A...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751823/ https://www.ncbi.nlm.nih.gov/pubmed/24009703 http://dx.doi.org/10.1371/journal.pone.0072743 |
_version_ | 1782281677019545600 |
---|---|
author | Benfield, Thomas Skovgaard, Marlene Schønheyder, Henrik Carl Knudsen, Jenny Dahl Bangsborg, Jette Østergaard, Christian Slotved, Hans-Christian Konradsen, Helle Bossen Thomsen, Reimar Wernich Lambertsen, Lotte |
author_facet | Benfield, Thomas Skovgaard, Marlene Schønheyder, Henrik Carl Knudsen, Jenny Dahl Bangsborg, Jette Østergaard, Christian Slotved, Hans-Christian Konradsen, Helle Bossen Thomsen, Reimar Wernich Lambertsen, Lotte |
author_sort | Benfield, Thomas |
collection | PubMed |
description | BACKGROUND: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report serotypes, their associated disease potential and coverage of pneumococcal conjugate vaccines (PCV) in adults with NBP and compare these to bacteremic pneumonia (BP). METHODS: Adults with pneumonia and Streptococcus pneumoniae isolated from the lower respiratory tract or blood were included 1 year in a population-based design in Denmark. Pneumonia was defined as a new infiltrate on chest radiograph in combination with clinical symptoms or elevated white blood count or plasma C-reactive protein. All isolates were serotyped using type-specific pneumococcal rabbit antisera. All values are medians with interquartile ranges. RESULTS: There were 272 cases of NBP and 192 cases of BP. Ninety-nine percent were hospitalized. NBP and BP cases were of comparable age and sex but NBP cases had more respiratory symptoms and less severe disease compared to BP cases. In total, 46 different serotypes were identified. Among NBP cases, 5 serotypes accounted for nearly a third of isolates. PCV10 and -13 types covered 17% (95% confidence interval (CI): 11-23%) and 34% (95% CI: 25-43%) of NBP isolates, respectively. In contrast, the five most frequent serotypes accounted for two-thirds of BP isolates. PCV10 and -13 types covered 39% (95% CI: 30-48%) and 64% (95% CI: 48-79) of BP isolates, respectively. More severe NBP disease was associated with infection with invasive serotypes while there was an inverse relationship for BP. CONCLUSIONS: Only a third of cases of adult non-bacteremic pneumococcal pneumonia would potentially be preventable with the use of PCV13 and just one sixth of cases with the use of PCV10 indicating that PCVs with increased valency are needed to increase vaccine coverage for NBP in adults. PCV13 could potentially prevent two-thirds of adult bacteremic pneumococcal pneumonia. |
format | Online Article Text |
id | pubmed-3751823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37518232013-09-05 Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines Benfield, Thomas Skovgaard, Marlene Schønheyder, Henrik Carl Knudsen, Jenny Dahl Bangsborg, Jette Østergaard, Christian Slotved, Hans-Christian Konradsen, Helle Bossen Thomsen, Reimar Wernich Lambertsen, Lotte PLoS One Research Article BACKGROUND: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report serotypes, their associated disease potential and coverage of pneumococcal conjugate vaccines (PCV) in adults with NBP and compare these to bacteremic pneumonia (BP). METHODS: Adults with pneumonia and Streptococcus pneumoniae isolated from the lower respiratory tract or blood were included 1 year in a population-based design in Denmark. Pneumonia was defined as a new infiltrate on chest radiograph in combination with clinical symptoms or elevated white blood count or plasma C-reactive protein. All isolates were serotyped using type-specific pneumococcal rabbit antisera. All values are medians with interquartile ranges. RESULTS: There were 272 cases of NBP and 192 cases of BP. Ninety-nine percent were hospitalized. NBP and BP cases were of comparable age and sex but NBP cases had more respiratory symptoms and less severe disease compared to BP cases. In total, 46 different serotypes were identified. Among NBP cases, 5 serotypes accounted for nearly a third of isolates. PCV10 and -13 types covered 17% (95% confidence interval (CI): 11-23%) and 34% (95% CI: 25-43%) of NBP isolates, respectively. In contrast, the five most frequent serotypes accounted for two-thirds of BP isolates. PCV10 and -13 types covered 39% (95% CI: 30-48%) and 64% (95% CI: 48-79) of BP isolates, respectively. More severe NBP disease was associated with infection with invasive serotypes while there was an inverse relationship for BP. CONCLUSIONS: Only a third of cases of adult non-bacteremic pneumococcal pneumonia would potentially be preventable with the use of PCV13 and just one sixth of cases with the use of PCV10 indicating that PCVs with increased valency are needed to increase vaccine coverage for NBP in adults. PCV13 could potentially prevent two-thirds of adult bacteremic pneumococcal pneumonia. Public Library of Science 2013-08-23 /pmc/articles/PMC3751823/ /pubmed/24009703 http://dx.doi.org/10.1371/journal.pone.0072743 Text en © 2013 Benfield et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Benfield, Thomas Skovgaard, Marlene Schønheyder, Henrik Carl Knudsen, Jenny Dahl Bangsborg, Jette Østergaard, Christian Slotved, Hans-Christian Konradsen, Helle Bossen Thomsen, Reimar Wernich Lambertsen, Lotte Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines |
title | Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines |
title_full | Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines |
title_fullStr | Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines |
title_full_unstemmed | Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines |
title_short | Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines |
title_sort | serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751823/ https://www.ncbi.nlm.nih.gov/pubmed/24009703 http://dx.doi.org/10.1371/journal.pone.0072743 |
work_keys_str_mv | AT benfieldthomas serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT skovgaardmarlene serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT schønheyderhenrikcarl serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT knudsenjennydahl serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT bangsborgjette serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT østergaardchristian serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT slotvedhanschristian serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT konradsenhellebossen serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT thomsenreimarwernich serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines AT lambertsenlotte serotypedistributioninnonbacteremicpneumococcalpneumoniaassociationwithdiseaseseverityandimplicationsforpneumococcalconjugatevaccines |